شنبه 1 اردیبهشت 1403
دوره 10، شماره 1 - ( 11-1400 )
جلد 10 شماره 1 صفحات 72-67 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saffari F, Arad B. Treatment of Hypertension in a Child With 11Beta-Hydroxylase Deficiency: A Case Report. J. Pediatr. Rev 2022; 10 (1) :67-72
URL: http://jpr.mazums.ac.ir/article-1-421-fa.html
URL: http://jpr.mazums.ac.ir/article-1-421-fa.html
Treatment of Hypertension in a Child With 11Beta-Hydroxylase Deficiency: A Case Report. Journal of Pediatrics Review. 1400; 10 (1) :67-72
چکیده: (1908 مشاهده)
Background: 11beta-hydroxylase deficiency (11βOHD) is clinically presented with external genitalia virilization in girls and precocious puberty in boys. Low renin hypertension occurs in both sexes. Early diagnosis and treatment of hypertension can prevent complications.
Objectives: To provide a practical management for controlling hypertension in patients with 11-beta-hydroxylase deficiency.
Methods: We described a 4.5 years old girl of 46.XX, who presented with ambiguous genitalia at birth and hypertension later in follow-up. The patient had received the appropriate dosage of hydrocortisone and the level of 17-hydroxy progesterone was within the acceptable range but the hypokalemia persisted. Both hypertension and hypokalemia were normalized when spironolactone was added.
Results: Blocking mineralocorticoid receptor treat hypertension in 11-beta-hydroxylase deficiency.
Conclusions: Intermittent measurement of blood pressure is necessary for patients with 11βOHD. In these patients, spironolactone is effective in treating mineralocorticoid-mediated hypertension and hypokalemia by blocking mineralocorticoid receptors.
Objectives: To provide a practical management for controlling hypertension in patients with 11-beta-hydroxylase deficiency.
Methods: We described a 4.5 years old girl of 46.XX, who presented with ambiguous genitalia at birth and hypertension later in follow-up. The patient had received the appropriate dosage of hydrocortisone and the level of 17-hydroxy progesterone was within the acceptable range but the hypokalemia persisted. Both hypertension and hypokalemia were normalized when spironolactone was added.
Results: Blocking mineralocorticoid receptor treat hypertension in 11-beta-hydroxylase deficiency.
Conclusions: Intermittent measurement of blood pressure is necessary for patients with 11βOHD. In these patients, spironolactone is effective in treating mineralocorticoid-mediated hypertension and hypokalemia by blocking mineralocorticoid receptors.
نوع مطالعه: Case Report and Review of Literature |
دریافت: 1400/4/20 | پذیرش: 1400/7/18 | انتشار: 1400/10/11
دریافت: 1400/4/20 | پذیرش: 1400/7/18 | انتشار: 1400/10/11
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
